M
Martha Campbell-Thompson
Researcher at University of Florida
Publications - 174
Citations - 10090
Martha Campbell-Thompson is an academic researcher from University of Florida. The author has contributed to research in topics: Type 1 diabetes & Pancreas. The author has an hindex of 54, co-authored 160 publications receiving 8861 citations. Previous affiliations of Martha Campbell-Thompson include American College of Veterinary Surgeons & Core Laboratories.
Papers
More filters
Journal ArticleDOI
Heme oxygenase-1 modulates early inflammatory responses: evidence from the heme oxygenase-1-deficient mouse.
Matthias H. Kapturczak,Clive Wasserfall,Todd M. Brusko,Martha Campbell-Thompson,Tamir M. Ellis,Mark A. Atkinson,Anupam Agarwal +6 more
TL;DR: In this article, the authors examined the differences in immune phenotype between HO-1 knockout (HO-1−/−) and wild-type (HME oxygenase-1+/+) mice.
Journal Article
Expression of estrogen receptor (ER) subtypes and ERbeta isoforms in colon cancer.
TL;DR: Data show that ERbeta is the predominant ER subtype in the human colon and that decreased levels of ER beta1 and ERbeta2 mRNA are associated with colonic tumorigenesis in females, which suggests that activation of ERbeta-mediated processes in the superficial colonic epithelium may have a role in the preventive effects observed for female gender and ERT usage.
Journal ArticleDOI
Marked Expansion of Exocrine and Endocrine Pancreas With Incretin Therapy in Humans With Increased Exocrine Pancreas Dysplasia and the Potential for Glucagon-Producing Neuroendocrine Tumors
Alexandra E. Butler,Martha Campbell-Thompson,Tatyana Gurlo,David W. Dawson,Mark A. Atkinson,Peter C. Butler +5 more
TL;DR: In conclusion, incretin therapy in humans resulted in a marked expansion of the exocrine and endocrine pancreatic compartments, the former being accompanied by increased proliferation and dysplasia and the latter by α-cell hyperplasia with the potential for evolution into neuroendocrine tumors.
Journal ArticleDOI
Nanodroplet processing platform for deep and quantitative proteome profiling of 10-100 mammalian cells.
Ying Zhu,Paul D. Piehowski,Rui Zhao,Jing Chen,Yufeng Shen,Ronald J. Moore,Anil K. Shukla,Vladislav A. Petyuk,Martha Campbell-Thompson,Clayton E. Mathews,Richard D. Smith,Wei-Jun Qian,Ryan T. Kelly +12 more
TL;DR: A robotically controlled chip-based nanodroplet processing platform is established and its ability to profile the proteome from 10–100 mammalian cells is demonstrated, illustrating the application of nanoPOTS for spatially resolved proteome measurements from clinical tissues.
Journal ArticleDOI
Diabetic endothelial nitric oxide synthase knockout mice develop advanced diabetic nephropathy
Takahiko Nakagawa,Waichi Sato,Olena Glushakova,Marcelo Heinig,Tracy Clarke,Martha Campbell-Thompson,Yukio Yuzawa,Mark A. Atkinson,Richard J. Johnson,Byron P. Croker,Byron P. Croker +10 more
TL;DR: Inhibition of eNO predisposes mice to classic diabetic nephropathy, likely due to VEGF-NO uncoupling with excessive endothelial cell proliferation coupled with altered autoregulation consequent to the development of preglomerular arteriolar disease.